News Review: Novogen Limited, Infinity Pharmaceuticals Inc., Wal-Mart Stores, Inc., Gilead Sciences, Inc.

Lakeway, TX -- (SBWIRE) -- 02/19/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Novogen Limited (ADR)(NASDAQ:NVGN) soars a whopping 126% after lab studies show that its CS-6 compound quickly killed ovarian cancer stem cells at low concentrations, and it destroyed regular cancer cells. The stem cells are almost totally resistant to radiotherapy and standard anti-cancer treatments, with studies identifying ovarian cancer stem cells as the source of the disease returning, the main cause of death in patients.

How Should Investors Trade NVGN After The Solid Jump? Let’s Find Out Here

Infinity Pharmaceuticals Inc.(NASDAQ:INFI) soars 12% after Morgan Stanley initiates coverage with an Overweight rating and a price-target of $47. "Infinity's wholly-owned early stage IPI-145 for blood cancers has shown positive early data and is on track to figure significantly in an emerging BCR drug class with multi-billion dollar potential. 2013 holds multiple catalysts to further validate IPI-145's efficacy/safety," firm says.

Is INFI Ready To Jump Again After The Solid Momentum? Get Free Trend Analysis Her

No comeback for Wal-Mart Stores, Inc.(NYSE:WMT) just yet after last week's leaked internal email painted an ugly picture on February sales to push shares lower. Traders were a bit edgy over what Wall Street firms would say over the development, but so far only boutique firm Oracle Investment Research is in with a downgrade, moving to a Sell rating with a soft $60 price target.

Is WMT A Buy After The Recent Price Movement? Find Out Here

Gilead Sciences, Inc.(NASDAQ:GILD) once-daily Sofosbuvir hepatitis C drug met the goals of a fourth Phase III study, this time in patients who had failed prior treatments. With all four trials providing positive results, Gilead is on track to file regulatory applications in the EU and U.S. in Q2.

Is GILD a Buy At The Current Market Price? Don’t Miss Out Our Special Coverage Here

About vbtrendreport.com
vbtrendreport.com’s team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by vbtrendreport.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. vbtrendreport.com does expect that investors will buy and sell securities based on information assembled and presented in vbtrendreport.com. PLEASE always do your own due diligence, and consult your financial advisor.